These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 27974550
1. A comparative effectiveness trial of two faecal immunochemical tests for haemoglobin (FIT). Assessment of test performance and adherence in a single round of a population-based screening programme for colorectal cancer. Passamonti B, Malaspina M, Fraser CG, Tintori B, Carlani A, D'Angelo V, Galeazzi P, Di Dato E, Mariotti L, Bulletti S, D'Amico MR, Gustinucci D, Martinelli N, Spita N, Cesarini E, Rubeca T, Giaimo M, Segnan N, Senore C. Gut; 2018 Mar; 67(3):485-496. PubMed ID: 27974550 [Abstract] [Full Text] [Related]
2. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study. Schreuders EH, Grobbee EJ, Nieuwenburg SAV, Kapidzic A, van Roon AHC, van Vuuren AJ, Lansdorp-Vogelaar I, Spijker WWJ, Izelaar K, Bruno MJ, Kuipers EJ, Spaander MCW. Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):622-631. PubMed ID: 31196734 [Abstract] [Full Text] [Related]
3. A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening. Grobbee EJ, van der Vlugt M, van Vuuren AJ, Stroobants AK, Mundt MW, Spijker WJ, Bongers EJC, Kuipers EJ, Lansdorp-Vogelaar I, Bossuyt PM, Dekker E, Spaander MCW. Gut; 2017 Nov; 66(11):1975-1982. PubMed ID: 27507905 [Abstract] [Full Text] [Related]
4. Performance of two faecal immunochemical tests for the detection of advanced neoplasia at different positivity thresholds: a cross-sectional study of the Dutch national colorectal cancer screening programme. de Klerk CM, Wieten E, Lansdorp-Vogelaar I, Bossuyt PM, Spaander MC, Dekker E. Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):111-118. PubMed ID: 30497962 [Abstract] [Full Text] [Related]
5. Long-term performance of colorectal cancerscreening programmes based on the faecal immunochemical test. Zorzi M, Hassan C, Capodaglio G, Fedato C, Montaguti A, Turrin A, Rosano A, Monetti D, Stocco C, Baracco S, Russo F, Repici A, Rugge M. Gut; 2018 Dec; 67(12):2124-2130. PubMed ID: 29101260 [Abstract] [Full Text] [Related]
6. Choice of faecal immunochemical test matters: comparison of OC-Sensor and HM-JACKarc, in the assessment of patients at high risk of colorectal cancer. Chapman CJ, Banerjea A, Humes DJ, Allen J, Oliver S, Ford A, Hardy K, Djedovic N, Logan RF, Morling JR. Clin Chem Lab Med; 2021 Mar 26; 59(4):721-728. PubMed ID: 33112776 [Abstract] [Full Text] [Related]
7. Attendance and diagnostic yield of repeated two-sample faecal immunochemical test screening for colorectal cancer. Kapidzic A, van Roon AH, van Leerdam ME, van Vuuren AJ, van Ballegooijen M, Lansdorp-Vogelaar I, Spijker W, Izelaar K, Hol L, Kuipers EJ. Gut; 2017 Jan 26; 66(1):118-123. PubMed ID: 26370109 [Abstract] [Full Text] [Related]
8. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis. Westwood M, Corro Ramos I, Lang S, Luyendijk M, Zaim R, Stirk L, Al M, Armstrong N, Kleijnen J. Health Technol Assess; 2017 May 26; 21(33):1-234. PubMed ID: 28643629 [Abstract] [Full Text] [Related]
9. Faecal haemoglobin concentration among subjects with negative FIT results is associated with the detection rate of neoplasia at subsequent rounds: a prospective study in the context of population based screening programmes in Italy. Senore C, Zappa M, Campari C, Crotta S, Armaroli P, Arrigoni A, Cassoni P, Colla R, Fracchia M, Gili F, Grazzini G, Lolli R, Menozzi P, Orione L, Polizzi S, Rapi S, Riggi E, Rubeca T, Sassatelli R, Visioli C, Segnan N. Gut; 2020 Mar 26; 69(3):523-530. PubMed ID: 31455608 [Abstract] [Full Text] [Related]
10. Equivalent Accuracy of 2 Quantitative Fecal Immunochemical Tests in Detecting Advanced Neoplasia in an Organized Colorectal Cancer Screening Program. Wieten E, de Klerk CM, van der Steen A, Ramakers CR, Kuipers EJ, Hansen BE, Lansdorp-Vogelaar I, Bossuyt PM, Dekker E, Spaander MCW. Gastroenterology; 2018 Nov 26; 155(5):1392-1399.e5. PubMed ID: 30055170 [Abstract] [Full Text] [Related]
11. Diagnostic accuracy of faecal biomarkers in detecting colorectal cancer and adenoma in symptomatic patients. Widlak MM, Thomas CL, Thomas MG, Tomkins C, Smith S, O'Connell N, Wurie S, Burns L, Harmston C, Evans C, Nwokolo CU, Singh B, Arasaradnam RP. Aliment Pharmacol Ther; 2017 Jan 26; 45(2):354-363. PubMed ID: 27910113 [Abstract] [Full Text] [Related]
12. Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program. Wieten E, Schreuders EH, Nieuwenburg SA, Hansen BE, Lansdorp-Vogelaar I, Kuipers EJ, Bruno MJ, Spaander MC. Clin Gastroenterol Hepatol; 2016 Dec 26; 14(12):1771-1777. PubMed ID: 27567693 [Abstract] [Full Text] [Related]
13. Contribution of the OC Sensor® immunoassay in comparison to the Hemoccult II® guaiac-test in organized colorectal cancer screening. Vitellius C, Laly M, Banaszuk AS, Deherce I, Cornet N, Bertrais S, Saulnier P, Caroli-Bosc FX. Eur J Epidemiol; 2019 Feb 26; 34(2):163-172. PubMed ID: 30536183 [Abstract] [Full Text] [Related]
14. Faecal immunochemical test in subjects not attending screening computed tomography colonography and colonoscopy in a randomized trial. Sali L, Ventura L, Mascalchi M, Falchini M, Mantellini P, Delsanto S, Milani S, Zappa M, Grazzini G. Eur J Cancer Prev; 2018 Mar 26; 27(2):105-109. PubMed ID: 27428397 [Abstract] [Full Text] [Related]
15. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening. Quintero E, Carrillo M, Gimeno-García AZ, Hernández-Guerra M, Nicolás-Pérez D, Alonso-Abreu I, Díez-Fuentes ML, Abraira V. Gastroenterology; 2014 Nov 26; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679 [Abstract] [Full Text] [Related]
16. Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results from a pilot study within the national screening programme in England. Moss S, Mathews C, Day TJ, Smith S, Seaman HE, Snowball J, Halloran SP. Gut; 2017 Sep 26; 66(9):1631-1644. PubMed ID: 27267903 [Abstract] [Full Text] [Related]
17. Single CT colonography versus three rounds of faecal immunochemical test for population-based screening of colorectal cancer (SAVE): a randomised controlled trial. Sali L, Ventura L, Mascalchi M, Falchini M, Mallardi B, Carozzi F, Milani S, Zappa M, Grazzini G, Mantellini P. Lancet Gastroenterol Hepatol; 2022 Nov 26; 7(11):1016-1023. PubMed ID: 36116454 [Abstract] [Full Text] [Related]
18. Difference in performance of fecal immunochemical tests with the same hemoglobin cutoff concentration in a nationwide colorectal cancer screening program. Chiang TH, Chuang SL, Chen SL, Chiu HM, Yen AM, Chiu SY, Fann JC, Chou CK, Lee YC, Wu MS, Chen HH. Gastroenterology; 2014 Dec 26; 147(6):1317-26. PubMed ID: 25200099 [Abstract] [Full Text] [Related]
19. Analytical evaluation of four faecal immunochemistry tests for haemoglobin. Piggott C, Carroll MRR, John C, O'Driscoll S, Benton SC. Clin Chem Lab Med; 2020 Jul 21; 59(1):173-178. PubMed ID: 32692692 [Abstract] [Full Text] [Related]
20. Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance. Westwood M, Lang S, Armstrong N, van Turenhout S, Cubiella J, Stirk L, Ramos IC, Luyendijk M, Zaim R, Kleijnen J, Fraser CG. BMC Med; 2017 Oct 24; 15(1):189. PubMed ID: 29061126 [Abstract] [Full Text] [Related] Page: [Next] [New Search]